For example, RRM2 activated the AKT pathway by directly binding to and stabilizing ANXA1 in renal cell carcinoma, and in HCC cells it sustained intracellular glutathione (GSH) by protecting glutathione synthetase (GSS) from degradation [26, 27]. This evidence concerns the gene GSS and hepatocellular carcinoma.